Bahrain conducts 1st CRISPR-based sickle cell treatment outside U.S.


By [e]Lydf

MANAMA, Feb. 16 (Xinhua) -- Bahrain has achieved a medical milestone by successfully treating a patient with sickle cell disease (SCD) using CRISPR-based gene-editing therapy, Casgevy, the Bahrain Oncology Center said on Sunday.

It marks the first successful treatment of its kind outside the United States, according to the institution.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Video shows final, confused moments of survivors of U.S. boat strike in Caribbean, say sources
Deadly Sumatra flooding triggers memories of Indian Ocean tsunami
German parliament vote on pensions tests Merz's authority
Oprah Winfrey praises Australia's social media ban for children
Harvard professor arrested by US immigration agents after firing pellet gun near synagogue
US widens travel ban to more than 30 countries, Noem says
Somalis arrested in Minneapolis immigration operation, officials say
Honduras presidential candidate Nasralla says Trump’s interference damaged his election chances
Russia's Putin to hold summit talks with India's Modi in Delhi
Bondi orders US law enforcement to investigate 'extremist groups'

Others Also Read